Fig. 3From: Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma ConsortiumImpact of HSCT on the survival of the patients with positive p53 expression. The OS (A) and PFS (B) were compared among the patients treated with Auto-SCT or Allo-SCT or without HSCTBack to article page